Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-004263
Filing Date
2023-04-26
Accepted
2023-04-26 17:30:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 29078
2 filename2.txt TEXT-EXTRACT 3636
  Complete submission text file 0000000000-23-004263.txt   44330
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filed for) CIK: 0001640455 (see all company filings)

EIN.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)